BioSpace News Archive

BioCapital

Processa Pharmaceuticals Raises $6.88 Million From Private Placements

Processa Pharmaceuticals, Inc. (OTC: PCSA) is pleased to announce it has raised a total of $6.88 million from private placements.

June 1, 2018
·
4 min read
BioCapital

CHADIS Named App of the Month for June 2018 by Allscripts

CHADIS, from Total Child Health was named app of the month by Allscripts for June 2018.

June 1, 2018
·
2 min read
BioMidwest

Next Level Trainings leadership group raises $224,673 in 27 days to fight child sex trafficking in Central Ohio

53 adults, ranging from 21 to 74 years of age, put together a spontaneous but intentional fundraising campaign to support children who have been sex trafficked in the Central Ohio region.

June 1, 2018
·
2 min read
Drug Development

Phase 3 A.R.R.O.W. Interim Analysis Shows Once-Weekly 70 mg/m2 KYPROLIS® (carfilzomib) Regimen Significantly Extended Progression-Free Survival Versus A Twice-Weekly 27 mg/m2 Regimen In Patients With Relapsed And Refractory Multiple Myeloma

Amgen announced results from the Phase 3 A.R.R.O.W. trial of a once-weekly KYPROLIS®

June 1, 2018
·
19 min read
Drug Development

Clinical Data for Zymeworks’ Novel Bispecific Antibody, ZW25, Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting

Zymeworks Inc. announced the presentation of ZW25 clinical data by Funda Meric-Bernstam, MD, Principal Investigator for the ZW25 study at the University of Texas MD Anderson Cancer Center.

June 1, 2018
·
9 min read
Genetown

PerkinElmer to Present at Goldman Sachs Global Healthcare Conference

PerkinElmer, Inc. announced that the Company will present at the 38th annual Goldman Sachs Global Healthcare Conference.

June 1, 2018
·
1 min read
Valeant Announces Closing Of Amended And Restated Credit Agreement Transaction And Senior Notes Offering, As Well As Redemption Of Existing Senior Notes

Valeant Pharmaceuticals International, Inc. announced that it has entered into a Fourth Amended & Restated Credit and Guaranty Agreement effectuating a full refinancing of its secured revolving and term loan credit facilities, and closed the previously announced offering of 8.500% Senior Notes due 2027.

June 1, 2018
·
3 min read
Drug Development

IMBRUVICA® (ibrutinib) in Combination with Rituximab Showed Greater Efficacy Compared to Placebo Plus Rituximab in Patients with Waldenström’s Macroglobulinemia, a Rare and Incurable Form of Non-Hodgkin’s Lymphoma

The Janssen Pharmaceutical Companies of Johnson & Johnson announced results from a pre-planned interim analysis of the Phase 3 iNNOVATE (PCYC-1127) study evaluating the investigational use of IMBRUVICA® (ibrutinib) in combination with rituximab in relapsed/refractory and treatment-naïve patients with Waldenström’s macroglobulinemia (WM).

June 1, 2018
·
15 min read
Business

Nordic Nanovector Strengthens Management Team With Appointment of Maureen Deehan, PhD, as Head of Corporate Development and Strategy

Nordic Nanovector ASA (OSE: NANO) announces that Maureen Deehan, PhD, has been appointed as Head of Corporate Development and Strategy.

June 1, 2018
·
2 min read
CENTOGENE to Present at the Jefferies 2018 Global Healthcare Conference

CENTOGENE announced that Richard Stoffelen, Chief Financial Officer of CENTOGENE, will present at the upcoming Jefferies 2018 Global Healthcare Conference.

June 1, 2018
·
1 min read